Regulated development in medical devices: from the lab to the patient

A medical device is not just a prototype that “works on the bench”: it is a product whose design must be shown to be safe and effective under the applicable regulatory framework. That implies design controls: user and system requirements, risk management, design architecture, and traceability from each requirement to the tests that verify or validate it.

Verification answers “did we build it right?” (does it meet the specification?). Validation answers “did we build the right product?” (does it serve the intended use with real users or representative environments?). For hardware (detectors, electronics, mechanics) and software (firmware, DAQ, reconstruction, interfaces), evidence must be documented and reproducible.

For medical imaging or critical instrumentation teams, multidisciplinary groups (physics, electronics, software, quality) need cadence and quality gates: avoid piling up technical or documentation debt at the end of the project. Early architecture decisions—for example in data acquisition or in partitioning between FPGA, ASIC, and host—shape years of maintenance and audits.

For those leading product or technology in MedTech, the challenge is to align innovation with regulatory predictability: the same engineering standards as in aerospace or space, applied to a domain where errors have a direct impact on health. That discipline is what allows moving from the lab to a device that can be used with confidence in clinical or regulated research settings.